AVXL
Anavex Life Sciences Corp. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website anavex.com
- Employees(FY) 40
- ISIN US0327973006
Performance
+17.27%
1W
+10.44%
1M
-19.75%
3M
-24.29%
6M
-51.13%
YTD
-52.11%
1Y
Profile
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases. Its lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome. The company's drug candidate also comprises ANAVEX 3-71, which is in clinical trial for the treatment of schizophrenia, frontotemporal dementia, and Alzheimer's disease. Its preclinical drug candidates include ANAVEX 1-41 for the treatment of depression, stroke, and neurogenerative disease; ANAVEX 1066 for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company was incorporated in 2004 and is headquartered in New York, New York.
Investment Analysis Report: AVXL
Overview:
AVXL is a biotechnology company operating in the Health Technology sector with a market capitalization of $465,577,931. In this report, we will conduct a comprehensive analysis of AVXL's financial health, earnings and revenue growth, profitability, operating margin, operating cash flow, capital expendit...
Technical Analysis of AVXL 2024-05-10
Overview:
In analyzing the technical indicators for AVXL over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key factors, we aim to offer valuable insights and predictions for potential invest...
Recent News & Updates
- 2024-05-15 00:00
- 2024-05-13 22:15
- 2024-05-13 19:30
- 2024-05-09 23:18
- 2024-05-08 19:41
Anavex Life Sciences: Fiscal Q2 Earnings Snapshot(Yahoo Finance)
- 2024-05-08 19:30
- 2024-05-01 19:30
- 2024-04-21 17:45
- 2024-04-10 19:30
- 2024-03-30 13:46
- 2024-03-28 01:18
- 2024-03-24 23:55
- 2024-03-24 19:30
- 2024-03-17 19:30
- 2024-03-14 17:45
- 2024-03-03 22:46
- 2024-02-26 00:14
12 $10 Stocks That Will Triple(Yahoo Finance)
- 2024-02-25 18:30
- 2024-02-08 09:39
- 2024-02-07 20:39
- 2024-02-07 07:43
Anavex Life Sciences: Fiscal Q1 Earnings Snapshot(Associated Press Finance)
- 2024-02-07 07:30
- 2024-02-06 18:30
- 2024-02-01 07:30
- 2024-01-31 18:30
- 2024-01-31 12:18
- 2024-01-31 12:11
- 2024-01-31 09:55
- 2024-01-30 20:55
- 2024-01-24 12:00
Page 1 of 5
previousnext